Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Olive

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Molecular Immunology|January 1, 1994
Functional expression of human CD28 in murine T cell hybridomasD Couez, F Pagès, M Ragueneau, et al.
Leukemia|April 29, 1998
Malignant plasma cell lines express a functional CD28 moleculeX G Zhang, D Olive, J Devos, et al.
Journal De Radiologie|August 1, 1985
[Neuroblastoma of the tail of the pancreas. Apropos of a case]M A Vouriot, A L Marchal, D Olive, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) geneC Cerdan, D Razanajaona, Y Martin, et al.
Archives Francaises De Pediatrie|April 1, 1988
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children]P Chastagner, D Olive, T Philip, et al.
Human Reproduction (Oxford, England)|April 28, 2000
Empty follicle syndrome: evidence for recurrenceT G Zreik, J A Garcia-Velasco, T M Vergara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activationF Michel, G Mangino, G Attal-Bonnefoy, et al.
Human Immunology|November 1, 1993
Anti-T11.1 and -T11.2 monoclonal antibodies play a different role in CD2-mediated signal transductionM Bagnasco, M D Franco, M Lopez, et al.
British Journal of Haematology|December 1, 1984
Allogeneic bone marrow transplantation in man: in vitro activity of FTS-Zn on T-cell markers and functionsP Bordigoni, M C Béné, G Faure, et al.
Human Immunology|May 1, 1987
Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sitesB Le Mauff, H Gascan, D Olive, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Molecular Immunology|January 1, 1994
Functional expression of human CD28 in murine T cell hybridomasD Couez, F Pagès, M Ragueneau, et al.
Leukemia|April 29, 1998
Malignant plasma cell lines express a functional CD28 moleculeX G Zhang, D Olive, J Devos, et al.
Journal De Radiologie|August 1, 1985
[Neuroblastoma of the tail of the pancreas. Apropos of a case]M A Vouriot, A L Marchal, D Olive, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) geneC Cerdan, D Razanajaona, Y Martin, et al.
Archives Francaises De Pediatrie|April 1, 1988
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children]P Chastagner, D Olive, T Philip, et al.
Human Reproduction (Oxford, England)|April 28, 2000
Empty follicle syndrome: evidence for recurrenceT G Zreik, J A Garcia-Velasco, T M Vergara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activationF Michel, G Mangino, G Attal-Bonnefoy, et al.
Human Immunology|November 1, 1993
Anti-T11.1 and -T11.2 monoclonal antibodies play a different role in CD2-mediated signal transductionM Bagnasco, M D Franco, M Lopez, et al.
British Journal of Haematology|December 1, 1984
Allogeneic bone marrow transplantation in man: in vitro activity of FTS-Zn on T-cell markers and functionsP Bordigoni, M C Béné, G Faure, et al.
Human Immunology|May 1, 1987
Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sitesB Le Mauff, H Gascan, D Olive, et al.
Pageof 31